Qualigen Therapeutics Inc
NASDAQ:QLGN
Qualigen Therapeutics Inc
NASDAQ:QLGN
Price:
2.33
USD
0.3%
Market Closed
Market Cap:
$4.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Qualigen Therapeutics Inc
NASDAQ:QLGN
|
US |
|
Deep Yellow Ltd
ASX:DYL
|
AU |
|
J
|
Jack Henry & Associates Inc
SWB:JHY
|
US |
|
E
|
Eni SpA
F:ENI1
|
IT |
|
Atrium Ljungberg AB
LSE:0IHM
|
SE |
|
M
|
MorphoSys AG
SWB:MOR2
|
DE |
|
First Republic Bank
OTC:FRCB
|
US |
|
S
|
Skechers USA Inc
F:SKAA
|
US |
|
PDS Biotechnology Corp
NASDAQ:PDSB
|
US |
|
C
|
CureVac NV
XBER:5CV
|
DE |
|
K
|
Kellanova
DUS:KEL
|
US |
|
Autobacs Seven Co Ltd
TSE:9832
|
JP |
DCF Valuation
is not available for Qualigen Therapeutics Inc
is not available for Qualigen Therapeutics Inc
QLGN's DCF value cannot be reliably calculated.
Switch to
Continue QLGN Research
Other Qualigen Therapeutics Inc listings:
Discover More
